Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database

BACKGROUND: Intravenous dantrolene is often prescribed for hypermetabolic syndromes other than the approved indication of malignant hyperthermia (MH). To clarify the extent of and indications for dantrolene use in conditions other than MH, we sought to document current practices in the frequency, di...

Descripción completa

Detalles Bibliográficos
Autores principales: Caroff, Stanley N., Roberts, Christopher B., Rosenberg, Henry, Tobin, Joseph R., Watt, Stacey, Mashman, Darlene, Riazi, Sheila, Berkowitz, Rosalind M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484236/
https://www.ncbi.nlm.nih.gov/pubmed/36123618
http://dx.doi.org/10.1186/s12871-022-01841-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484236/
https://www.ncbi.nlm.nih.gov/pubmed/36123618
http://dx.doi.org/10.1186/s12871-022-01841-z

Ejemplares similares